Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ceftezole is an α-Glucosidase inhibitor (IC50: 2.1 μM; Ki: 0.578 μM).
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
25 mg | 約6-8 週間 | ¥ 349,000 |
50 mg | 約6-8 週間 | ¥ 454,500 |
100 mg | 約6-8 週間 | ¥ 574,000 |
説明 | Ceftezole is an α-Glucosidase inhibitor (IC50: 2.1 μM; Ki: 0.578 μM). |
ターゲット&IC50 | α-glucosidase:(ki)0.578 μM , α-glucosidase:2.1 μM |
In vivo | In vivo streptozotocin-induced mouse model, blood glucose levels are decreased by 30% 20 min after Ceftezole treatment (10 mg/kg/day). Expression levels of GSK-3, peroxisome proliferator-activated receptor-γ, and uncoupling protein-3 mRNA are also slightly decreased compared to controls following Ceftezole treatment. |
分子量 | 437.52 |
分子式 | C16H15N5O4S3 |
CAS No. | 65307-12-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Cefetrizole 65307-12-2 Metabolism Glucokinase Inhibitor inhibitor inhibit